LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
64.97 27.76 3454 6656 0.5189 0.8407
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
64.97 27.76 2025 6656 0.3042 0.7205
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
64.97 27.76 2606 6656 0.3915 0.7763
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
64.97 27.76 580 6656 0.0871 0.4688
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
64.97 27.76 4149 6656 0.6233 0.8839
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
66.67 27.76 313 6695 0.0467 0.3581
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
66.67 27.76 3593 6695 0.5366 0.8487
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
66.67 27.76 2205 6695 0.3293 0.7381
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
66.67 27.76 2784 6695 0.4158 0.7901
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
66.67 27.76 631 6695 0.0942 0.4840
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
66.67 27.76 4377 6695 0.6537 0.8954
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
68.37 27.76 356 6879 0.0518 0.3782
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
68.37 27.76 3725 6879 0.5415 0.8515
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
68.37 27.76 2201 6879 0.3200 0.7330
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
68.37 27.76 2843 6879 0.4133 0.7897
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
68.37 27.76 668 6879 0.0971 0.4917
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
68.37 27.76 4484 6879 0.6518 0.8952
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
70.08 27.76 345 6849 0.0504 0.3731
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
70.08 27.76 3812 6849 0.5565 0.8578
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
70.08 27.76 2095 6849 0.3059 0.7230
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
70.08 27.76 2902 6849 0.4237 0.7951
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
70.08 27.76 640 6849 0.0934 0.4842
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
70.08 27.76 4603 6849 0.6720 0.9024
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
71.78 27.76 308 6893 0.0447 0.3532
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
71.78 27.76 3829 6893 0.5555 0.8575
MN20160318_Q01
E20